References
- Manos MJ, Tom-Revzon C, Bukstein OG, Crismon ML. Changes and challenges: managing ADHD in a fast-paced world. J Manag Care Pharm 2005; 13: S2–13
- Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239–245
- Pliszka SR, Crismon ML, Hughes CW, Corners CK, Emslie GJ, Jensen PS, et al. The Texas Children's Medication Algorithm Project: Revision of the algorithm for pharmacotherapy of attention-deficit/ hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2006; 45: 642–657
- Strattera (atomoxetine). Prescribing information. 2007. Indianapolis, IN: Eli Lilly and Company.
- Winocur E, Gavish A, Voikovitch M, Emodi-Prlman A, Eli I. Drugs and bruxism: A critical review. J Orofac Pain 2003; 17: 99–111